Newsletter Signup! Stay up-to-date by signing up to receive my newsletter. Click Here

Newsletter Signup! Stay up-to-date by signing up to receive my newsletter. Click Here

M

Tour Requests

Help With Casework

Student Resources

Meeting Requests

Grant Assistance

Budd, Graham, Colleagues Urge FDA to Defend Life by Reevaluating Dangerous Leading Chemical Abortion Drug Approved for Market

Oct 10, 2025 | Healthcare, Press Releases

Washington, D.C. — U.S. Senator Ted Budd (R-N.C.) joined Senator Lindsey Graham (R-S.C.)and 50 Senate Republicans in sending a letter to the U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr. and U.S. Food and Drug Administration (FDA) Commissioner, Dr. Martin Makary, urging them to review a recent decision to approve a generic version of mifepristonecurrently the leading drug used to perform chemical abortions. 

Mifepristone is not only a lethal drug for preborn babies but also poses a serious health risk for expectant mothers. Given recent statements from HHS and FDA acknowledging data discrepancies surrounding abortion pill safety and a commitment to review the science, the lawmakers argue that the Biden-era decision to remove safeguards not only undermines women’s reproductive health but also disregards pro-life laws in states across the country.  

In the letter, the Senators wrote, “We commend your recent statements acknowledging the data discrepancies surrounding abortion pill safety and your commitment to reviewing the science. We are also encouraged by HHS’s recent announcement that it will review prior Risk Evaluation and Mitigation Strategies (REMS) approvals given the recent studies raising concerns about the drug’s safety. Given this commitment, however, we are deeply concerned about the FDA’s approval of a new generic version of mifepristone. While we recognize the FDA’s statutory responsibility in evaluating drug applications, the timing of this approval appears inconsistent with the comprehensive safety reassessment your agencies have prioritized. Out of respect for this important review, and with full confidence in your dedication to protecting women’s health, states’ rights, and unborn life, we urge you to take decisive action to reevaluate whether this generic version of mifepristone is suitable to enter the market.”

They continued, “Unrestricted access to abortion pills is systematically undermining states’ rights and violating pro-life state laws. Every month, thousands of abortion drugs are shipped into states that have otherwise limited access to abortion after Dobbs, degrading pro-life laws at the state level across the country.”

Additional letter co-signers include U.S. Senators Jim Banks (R-Ind.), John Barrasso (R-Wyo.), Marsha Blackburn (R-Tenn.), John Boozman (R-Ark.), Katie Britt (R-Ala.), Shelley Moore Capito (R-W.Va.), Bill Cassidy (R-La.), John Cornyn (R-Texas), Tom Cotton (R-Ark.), Kevin Cramer (R-N.D.), Mike Crapo (R-Idaho), Ted Cruz (R-Texas), John Curtis (R-Utah), Steve Daines (R-Mont.), Joni Ernst (R-Iowa), Deb Fischer (R-Neb.), Charles Grassley (R-Iowa), Bill Hagerty (R-Tenn.), Josh Hawley (R-Mo.), John Hoeven (R-N.D.), Jon Husted (R-Ohio), Cindy Hyde-Smith (R-Miss.), Ron Johnson (R-Wis.), Jim Justice (R-W.Va.), John Kennedy (R-La.), James Lankford (R-Okla.), Mike Lee (R-Utah), Cynthia Lummis (R-Wyo.), Roger Marshall (R-Kan.), Mitch McConnell (R-Ky.), David McCormick (R-Pa.), Ashley Moody (R-Fla.), Jerry Moran (R-Kan.), Bernie Moreno (R-Ohio), Markwayne Mullin (R-Okla.), Rand Paul (R-Ky.), Pete Ricketts (R-Neb.), James Risch (R-Idaho), Mike Rounds (R-S.D.), Eric Schmitt (R-Mo.), Rick Scott (R-Fla.), Tim Scott (R-S.C.), Tim Sheehy (R-Mont.), Dan Sullivan (R-Alaska), John Thune (R-S.D.), Thom Tillis (R-N.C.), Tommy Tuberville (R-Ala.), Roger Wicker (R-Miss.), and Todd Young (R-Ind.).

Read the full letter text HERE.

###

Signup for Newsletter Updates

Latest News